A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers.

Clinical trial NCT07190716 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07190716
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Single Ascending Dose Healthy Subjects

Start date: 2025-10-10
Primary completion: 2026-05-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.